PANTHERx Rare is proud to congratulate our Marketing Specialist, Ally Ayoob, on her recognition as a 2020 Pittsburgh Business Times 30 Under 30 honoree. Each year, The Pittsburgh Business Times …
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Ultragenyx Pharmaceutical as a limited distribution partner for new drug DOJOLVITM (triheptanoin). DOJOLVI™ (a …
At PANTHERx Rare Pharmacy we provide our patients with resources to support and streamline their health journeys. In addition to our 24/7 call services, PANTHERx has implemented a mobile messaging …
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Viela Bio, Inc. as their sole rare pharmacy partner for new drug Uplizna™ (inebilizumab-cdon). …
Yesterday, PANTHERx Rare Pharmacy celebrated the achievements of our 2020 fellowship class. Graduates, Marissa Puc, Pharm.D., and Brittany Albert, Pharm.D., delivered their final presentations and received their certificates in recognition …
Read the Official PANTHERx Press Release. PANTHERx Rare Pharmacy (PANTHERx), was officially recognized as a prestigious US Best Managed Company for overall business performance and sustained growth. The US Best …
Read the Official PANTHERx Press Release. PANTHERx® Rare Pharmacy announces that it has been selected by Deciphera Pharmaceuticals as a limited distribution partner for new drug QINLOCKTM (ripretinib). QINLOCK™ is …
Read the Official PANTHERx Press Release. PANTHERx Rare Pharmacy (PANTHERx) has again been recognized as the winner of the annual, national Specialty Pharmacy Patient Choice Award™. “We are honored and …
Read the Official PANTHERx Press Release. In a landmark, non-commercial publication available for download, PANTHERx Rare Pharmacy explores the details of how changes in U.S. Federal policy and advances in …
PANTHERx Rare Pharmacy earns a spot on exclusive list as a Top 10 Specialty Pharmacy of 2019 as reported by Adam Fein, Ph.D., CEO of Drug Channels Institute. The list, …
